New drug trial aims to ease debilitating muscle stiffness
Disease control
Recruiting now
This early-stage trial is testing a new drug called ATX-01 in adults with myotonic dystrophy type 1 (DM1), a genetic disorder that causes progressive muscle weakness and stiffness. The main goal is to see if the drug is safe and well-tolerated when given as a single dose or as th…
Phase: PHASE1, PHASE2 • Sponsor: ARTHEx Biotech S.L. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC